STJ has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
This is the expense the company spent on research and development. St Jude Medical Inc's research and development for the three months ended in Sep. 2016 was $183 Mil. Its research and development for the trailing twelve months (TTM) ended in Sep. 2016 was $740 Mil.
This is the expense the company spent on research and development.
St Jude Medical Inc Research & Development for the trailing twelve months (TTM) ended in Sep. 2016 was 177 (Dec. 2015 ) + 188 (Mar. 2016 ) + 192 (Jun. 2016 ) + 183 (Sep. 2016 ) = $740 Mil.
* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.
If competitive advantage is created by a patent or tech advantage, at some point it will disappear.
High R&D usually dictates high SG&A which threatens the competitive advantage.
St Jude Medical Inc Annual Data
|Research & Development||431||476||532||560||643||705||676||691||692||676|
St Jude Medical Inc Quarterly Data
|Research & Development||178||169||175||167||171||161||177||188||192||183|